Header cover image

Dutch (AEX) Biotech Industry Analysis

UpdatedNov 22, 2024
DataAggregated Company Financials
Companies3
  • 7D-8.2%
  • 3M0.7%
  • 1Y-33.7%
  • YTD-38.0%

The Biotech industry is up 1.3% in the last week, with Galapagos up 3.3%. In contrast, the industry has lost 30% in the last 12 months. Looking forward, earnings are forecast to decline by 2.4% per year.

Industry Valuation and Performance

Has the Dutch Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 22 Nov 2024€2.1b€532.7m-€77,614,142.00n/a-26.4x3.8x
Sun, 20 Oct 2024€2.4b€516.9m€19.2m58.4x124.2x4.6x
Tue, 17 Sep 2024€2.3b€510.8m€19.5m56.9x116.2x4.4x
Thu, 15 Aug 2024€1.9b€513.4m€19.4m46.3x100.2x3.8x
Sat, 13 Jul 2024€2.2b€480.5m€20.8m53.7x105.2x4.6x
Mon, 10 Jun 2024€2.2b€482.8m€20.7m53.3x104.7x4.5x
Wed, 08 May 2024€2.4b€471.7m€20.9m58.5x114.7x5.1x
Fri, 05 Apr 2024€2.6b€466.1m-€39,612,789.40n/a-66.5x5.7x
Sun, 03 Mar 2024€3.0b€441.6m-€50,629,354.00n/a-60.1x6.9x
Tue, 30 Jan 2024€3.4b€745.9m-€199,721,382.00n/a-16.8x4.5x
Thu, 28 Dec 2023€3.3b€740.8m-€199,207,500.00n/a-16.8x4.5x
Sat, 25 Nov 2023€3.2b€744.0m-€199,531,709.00n/a-15.8x4.3x
Mon, 23 Oct 2023€3.1b€754.9m-€199,135,876.00n/a-15.4x4x
Wed, 20 Sep 2023€3.3b€753.2m-€199,001,248.00n/a-16.8x4.4x
Fri, 18 Aug 2023€3.4b€749.9m-€200,603,918.00n/a-16.9x4.5x
Sun, 16 Jul 2023€3.5b€727.3m-€211,406,747.00n/a-16.4x4.8x
Tue, 13 Jun 2023€3.7b€735.3m-€211,486,148.00n/a-17.5x5x
Thu, 11 May 2023€3.7b€735.3m-€197,162,047.0062x-18.9x5.1x
Sat, 08 Apr 2023€3.4b€704.6m-€219,020,309.0057.8x-15.5x4.8x
Mon, 06 Mar 2023€3.3b€707.7m-€202,997,836.0026.2x-16.5x4.7x
Wed, 01 Feb 2023€3.8b€775.6m€20.0m253.7x191.3x4.9x
Fri, 30 Dec 2022€3.7b€778.9m€20.5m258x181.2x4.8x
Sun, 27 Nov 2022€3.6b€783.9m€21.2m245.3x168.5x4.6x
Tue, 25 Oct 2022€3.7b€722.3m-€72,912,399.0029.6x-51.4x5.2x
Thu, 22 Sep 2022€4.0b€720.9m-€72,142,158.0036.2x-55.8x5.6x
Sat, 20 Aug 2022€4.4b€717.5m-€72,492,388.0036.3x-60.2x6.1x
Mon, 18 Jul 2022€4.1b€718.2m-€127,721,406.0045.2x-32.3x5.7x
Wed, 15 Jun 2022€4.0b€711.9m-€128,062,547.0043.3x-31.2x5.6x
Fri, 13 May 2022€4.2b€706.7m-€123,384,794.0030.9x-34.4x6x
Sun, 10 Apr 2022€5.1b€678.5m-€122,280,278.0038.2x-41.6x7.5x
Tue, 08 Mar 2022€4.2b€668.5m-€117,921,000.0024.5x-35.4x6.2x
Thu, 03 Feb 2022€4.7b€709.9m-€193,509,000.0029.8x-24.1x6.6x
Sat, 01 Jan 2022€4.1b€709.9m-€193,509,000.0026.3x-21.2x5.8x
Mon, 29 Nov 2021€3.6b€709.9m-€193,509,000.0025x-18.7x5.1x
Price to Earnings Ratio

-18.7x


Total Market Cap: €3.6bTotal Earnings: -€193,509,000.00Total Revenue: €709.9mTotal Market Cap vs Earnings and Revenue0%0%0%
Dutch Biotech Industry Price to Earnings3Y Average 13.4x202220232024
Current Industry PE
    There are only 3 companies in the Dutch Biotechs industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 9.2% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Dutch Healthcare industry?

NL Market-2.51%
Healthcare0.79%
Biotech-8.18%
Biotech-8.18%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

GLPG

€23.96

Galapagos

7D

-9.2%

1Y

-29.7%

PHARM

€0.69

Pharming Group

7D

-5.5%

1Y

-34.4%

VVY

€2.04

Vivoryon Therapeutics

7D

-0.7%

1Y

-74.3%